--- title: Neurology CDMOs path: /indications/neurology companies_count: 15 --- # Neurology CDMOs 15 published CDMOs match Neurology. Locations in this set include United States, United Kingdom, India, Australia, Canada, and China. Capabilities that show up most often in this set: CMC Analytical Development, Process Development, Quality Control Testing, CMC Regulatory Submission Support, and Stability Testing & Storage. ## Matching companies - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [AskBio](/companies/askbio) - AskBio is a clinical-stage gene therapy company developing AAV gene therapies for genetic and rare disorders, with a focus on advancing genetic technology and lowering production costs to increase patient access. - [Cell and Gene Therapy Catapult](/companies/ct) - UK-based innovation and manufacturing support organization for cell and gene therapies, offering infrastructure, expertise, and collaboration across the ATMP lifecycle. - [Charles River Laboratories](/companies/criver) - Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years. - [Esco Aster](/companies/escoaster) - Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology. - [Ethypharm](/companies/ethypharm) - Ethypharm is a leading mid-size international specialty pharmaceutical company with strong European roots. - [Forge Biologics](/companies/forgebiologics) - Dedicated AAV gene therapy CDMO with a 200,000+ sq. ft. cGMP facility featuring 20 suites and bioreactors up to 5,000L, supporting 60+ clients across 35+ indications with high-yield manufacturing and seamless regulatory compliance. - [Grifols Partnership](/companies/grifols) - CDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise. - [IDT Australia](/companies/idtaus-com) - IDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support. - [Maravai LifeSciences](/companies/maravai) - Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology. - [Mytos Inc.](/companies/mytos) - Mytos is an automated CDMO for regenerative medicines, using its iDEM platform to produce stem-cell derived therapies. The company says its automation lets clients scale in months rather than years at lower cost per batch. - [Optimus Drugs Private Limited](/companies/optimuspharma) - Leading CDMO delivering end-to-end small molecule drug substance and drug product development and manufacturing from clinical to commercial scale, with 21+ years of expertise and GMP-certified facilities. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Svar Life Science AB](/companies/svarlifescience) - Svar Life Science offers CRO services including bioanalytical testing, biomarker discovery, and GMP QC testing, alongside diagnostic services and cell manufacturing capabilities. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.